The connection between anti-TRIM21 antibodies and SLE-ILD is still not well understood in the current study among a limited group of SLE-ILD patients, but anti-TRIM21 antibodies positivity in SLE-ILD is greatly likely to be associated with negative patient outcomes, and the specific mechanism needs to be further explored. Here, TRIM21 is linked to interstitial lung disease.